Christine Mikail Cvijic, the President and CFO of $NGNE, sold 739 shares of the company on 07-01-2026 for an estimated $25,169. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.8% of their shares of this class of stock. Following this trade, they now own 92,901 shares of this class of $NGNE stock.
$NGNE Insider Trading Activity
$NGNE insiders have traded $NGNE stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $NGNE stock by insiders over the last 6 months:
- CHRISTINE MIKAIL CVIJIC (President and CFO) has made 0 purchases and 7 sales selling 11,403 shares for an estimated $306,078.
- STUART COBB (Chief Scientific Officer) has made 0 purchases and 3 sales selling 6,797 shares for an estimated $141,445.
- RACHEL MCMINN (Chief Executive Officer) sold 3,352 shares for an estimated $73,995
- JULIE JORDAN (Chief Medical Officer) sold 828 shares for an estimated $18,127
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$NGNE Hedge Fund Activity
We have seen 53 institutional investors add shares of $NGNE stock to their portfolio, and 24 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 252,318 shares (+193.6%) to their portfolio in Q1 2026, for an estimated $5,086,730
- LOGOS GLOBAL MANAGEMENT LP removed 195,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $3,931,200
- MILLENNIUM MANAGEMENT LLC added 133,488 shares (+187.2%) to their portfolio in Q1 2026, for an estimated $2,691,118
- CASDIN CAPITAL, LLC added 125,000 shares (+9.6%) to their portfolio in Q1 2026, for an estimated $2,520,000
- BALYASNY ASSET MANAGEMENT L.P. added 109,811 shares (+18.0%) to their portfolio in Q1 2026, for an estimated $2,213,789
- MORGAN STANLEY removed 85,935 shares (-23.2%) from their portfolio in Q1 2026, for an estimated $1,732,449
- BLACKROCK, INC. added 59,487 shares (+6.3%) to their portfolio in Q1 2026, for an estimated $1,199,257
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$NGNE Price Targets
Multiple analysts have issued price targets for $NGNE recently. We have seen 3 analysts offer price targets for $NGNE in the last 6 months, with a median target of $70.0.
Here are some recent targets:
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $70.0 on 06/09/2026
- Whitney Ijem from Canaccord Genuity set a target price of $180.0 on 04/06/2026
- Patrick Dolezal from LifeSci Capital set a target price of $50.0 on 01/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
